Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TVAX-028 in the Treatment of Chronic Hepatitis B

NCT07673068 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

HBV Infection

Interventions

DRUG: TVAX-028
OTHER: Adjuvant

Sponsor

Grand Theravac Life Sciences (Nanjing) Co., Ltd.